1. Home
  2. ACLX vs MMS Comparison

ACLX vs MMS Comparison

Compare ACLX & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • MMS
  • Stock Information
  • Founded
  • ACLX 2015
  • MMS 1975
  • Country
  • ACLX United States
  • MMS United States
  • Employees
  • ACLX 163
  • MMS N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • MMS Business Services
  • Sector
  • ACLX Health Care
  • MMS Consumer Discretionary
  • Exchange
  • ACLX Nasdaq
  • MMS Nasdaq
  • Market Cap
  • ACLX 3.5B
  • MMS 3.9B
  • IPO Year
  • ACLX 2022
  • MMS 1997
  • Fundamental
  • Price
  • ACLX $63.00
  • MMS $66.99
  • Analyst Decision
  • ACLX Strong Buy
  • MMS Buy
  • Analyst Count
  • ACLX 14
  • MMS 1
  • Target Price
  • ACLX $111.42
  • MMS $90.00
  • AVG Volume (30 Days)
  • ACLX 631.2K
  • MMS 432.6K
  • Earning Date
  • ACLX 08-07-2025
  • MMS 08-06-2025
  • Dividend Yield
  • ACLX N/A
  • MMS 1.79%
  • EPS Growth
  • ACLX N/A
  • MMS 31.21
  • EPS
  • ACLX N/A
  • MMS 5.00
  • Revenue
  • ACLX $76,809,000.00
  • MMS $5,395,260,000.00
  • Revenue This Year
  • ACLX N/A
  • MMS $2.13
  • Revenue Next Year
  • ACLX $112.68
  • MMS $3.36
  • P/E Ratio
  • ACLX N/A
  • MMS $13.41
  • Revenue Growth
  • ACLX N/A
  • MMS 5.29
  • 52 Week Low
  • ACLX $47.86
  • MMS $63.77
  • 52 Week High
  • ACLX $107.37
  • MMS $93.97
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 47.45
  • MMS 33.03
  • Support Level
  • ACLX $64.77
  • MMS $68.80
  • Resistance Level
  • ACLX $66.73
  • MMS $70.39
  • Average True Range (ATR)
  • ACLX 2.89
  • MMS 1.51
  • MACD
  • ACLX -0.35
  • MMS -0.51
  • Stochastic Oscillator
  • ACLX 25.18
  • MMS 5.08

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: